An affordable decades-old drug has been reformulated and repurposed to treat COVID-19 patients. Following FDA and Health Canada’s approval, the drug has now begun phase three of a North American clinical trial. As Global’s Victoria Bakos reports, patient recruitment is launching in two weeks in Quebec and Ontario.
Canada
Affordable, decades-old drug PULM-001 proves promising in the fight against COVID-19
More Videos
-
3 dead after car veers into oncoming traffic in Quebec’s Eastern Townships
-
Pro-Palestinian campus protesters organize for another week
-
McGill encampment enters second week as protestors say morale remains high
-
Montreal launches cruise season with ship that protected 1,500 Ukrainian refugees
-
Calls for a homeless shelter in Côte-des-Neiges-Notre-Dame-de-Grâce
-
Pro-Palestinian encampment on McGill University campus enters seventh day
You are viewing an Accelerated Mobile Webpage.
View Original Article